<DOC>
	<DOCNO>NCT00472966</DOCNO>
	<brief_summary>To determine effectiveness safety sequential therapy Tri-Luma® Cream series Glycolic Acid peel treatment moderate severe melasma .</brief_summary>
	<brief_title>Efficacy Safety Therapy With Tri-Luma® Cream Sequence With Glycolic Acid Peels Melasma</brief_title>
	<detailed_description>To determine efficacy safety sequential therapy Fluocinolone acetonide 0.01 % , Hydroquinone 4 % Tretinoin 0.05 % , series Glycolic Acid peel treatment moderate severe melasma .</detailed_description>
	<mesh_term>Melanosis</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Glycolic acid</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<mesh_term>Hydroquinone</mesh_term>
	<criteria>Subjects diagnose moderate severe melasma Subjects treatment dermatologic condition , may interfere safe evaluation study combination ( e.g . eczema , psoriasis , severe sundamage , dermatitis ) Subjects diagnosis skin cancer ( BCE , SCC , Melanoma ) area treat</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>